ALG3 p.Ala17=
c.51A>G · rs763727038 · VCV344361
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.01 | strongly benign-leaning |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -4.7 | GERP -2.8 |
| Overall | ||
| CADD | 6.622 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.143% | 701 |
| East Asian | 0.00449% | 22,252 |
| Remaining individualsnot grpmax-eligible | 0.00323% | 30,986 |
| European (non-Finnish) | 0.00017% | 587,772 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALG3
- Protein
- p.Ala17=
- Coding
- c.51A>G
- MANE Select
- NM_005787
- dbSNP
- rs763727038
- Type
- single nucleotide variant
- Location
- chr3:184248890 (GRCh38)
- Gene constraint
- LOEUF 0.972 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 89.05
Disease context
ALG3-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor ALG3-CDG (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- ALG3 p.Ala17Val Uncertain significance ★★ ⚠ same residue
- ALG3 p.Ala17Gly Uncertain significance ★ ⚠ same residue
- ALG3 c.444+1G>T Likely pathogenic ★★ same condition
- ALG3 p.Arg171Gln Pathogenic/Likely pathogenic ★★ same condition
- ALG3 p.Arg266Cys Pathogenic ★★ same condition
- ALG3 p.Arg354Cys Likely pathogenic ★★ same condition
- ALG3 p.Arg354His Pathogenic/Likely pathogenic ★★ same condition
- ALG3 p.Asn174Ser Likely pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alg3-p-ala17 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown